Neal James R 4
4 · Akari Therapeutics Plc · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Neal James R
Director
Transactions
- Award
Ordinary Shares, par value $0.0001 per share
2025-01-09$0.00/sh+8,000,000$4,800→ 32,216,000 total
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
- [F2]On January 9, 2025, the Reporting Person acquired 8,000,000 Ordinary Shares at a purchase price of $0.00065 per Ordinary Share.